Welcome to the 2021 SAPA Scientific Symposium!
Our event will start on May 22nd, 2021, at 9:00 AM EDT.
Please keep your confirmation email and this link with you during the event!
Download The Event Program
PLEASE READ:
– To join the meeting, click the corresponding JOIN MEETING link in the table below.
– Please contact us if you have any questions: event@sapaweb.org.
Session Zoom Link: Saturday, 5/22/2021
| Time | Session | Link |
|---|---|---|
| Plenary Session | JOIN MEETING | |
| 9:00 – 9:10 AM | Scientific Symposium Opening Remarks and SAPA Intro | |
| 9:10 – 9:50 AM | Induced Protein Degradation: A New Paradigm in Drug Discovery. Shaomeng Wang, Ph.D. | |
| 9:50 – 10:30 AM | Danger Associated Molecule Pattern (DAMP) Recognition and Host Defense to Tissue Injuries. Yang Liu, Ph.D. | |
| 10:40 – 11:20 AM | Delivering Transformative Treatments to Patients through Cell Therapy Innovation. Heidi Zhang, Ph.D. | |
| 11:20 AM – 12:00 PM | Fireside Chat. Robert Garbaccio, Ph.D. and Ho Sung Cho, Ph.D. | |
| 12:00 PM – 1:00 PM | Lunch break; SAPA events and sponsor promotions | |
| Parallel Session I | JOIN MEETING | |
| 1:00 – 1:40 PM | mRNA platform and mRNA-1273. Kai Wu, Ph.D. | |
| 1:40 – 2:20 PM | Designing ionizable lipids and lipid nanoparticles for mRNA vaccines, Michael Buschmann, Ph.D. | |
| 2:30 – 3:10 PM | What Happens After the Agreement: The Merck/Ridgeback Integration and the Development of Molnupiravir. William Morris, Ph.D. | |
| 3:10 – 3:50 PM | Oral Inhibitors of the SARS-CoV-2 Main Protease for the Treatment of COVID-19. Dafydd Owen, Ph.D. | |
| 4:00 – 5:00 PM | Breakout Interactive Session | |
| Parallel Session II | JOIN MEETING | |
| 1:00 – 1:40 PM | Preclinical Characterization of GQ1007, HER2 Ab Immune Agonist Conjugate Based on AIAC Platform with the Best-inclass Potential. Paul Song, Ph.D. | |
| 1:40 – 2:20 PM | Big Data, Big Benefits: How Big Data is Transforming Clinical Trial Recruitment in China？Can Chen and Yuzhu Ding | |
| 2:30 – 3:10 PM | Artificial Intelligence Perspectives and Tools for Genome Analysis and Drug Development. Lin, Ching-Yung, Ph.D. | |
| 3:10 – 3:50 PM | "CAR-T Cell Therapy Against Multiple Myeloma. Qiong Wang, MD, Ph.D. Head of US R&D, Legend Biotech; Regulatory Challenges and Strategies for the Development of Gene Therapy Products to Treat Rare Orphan Disease*, Jim Wang, Ph.D., MBA | |
| 4:00 – 5:00 PM | Breakout Interactive Session | |
| Parallel Session III | JOIN MEETING | |
| 1:00 – 1:40 PM | AI-powered Drug Discovery. Feng Ren, Ph.D. | |
| 1:40 – 2:20 PM | Targeted Protein Degradation (PROTAC) for Drug Discovery. Yue Xiong, Ph.D. | |
| 2:30 – 3:10 PM | Beyond the Target-based Approach, a New Omics-based Approach to Discover New Therapeutics. Bin Chen, Ph.D. | |
| 3:10 – 3:50 PM | Data-Driven Chemistry, Small Molecule Synthesis, and Design. Connor Coley, Ph.D. | |
| 4:00 – 5:00 PM | Breakout Interactive Session | |
| Business Social Hour | ||
| 5:00 – 6:00 PM | BMS & Deloitte Networking Room | JOIN MEETING |
| 5:00 – 6:00 PM | Innocare & Fox Rothschild Networking Room | JOIN MEETING |
| 5:00 – 6:00 PM | Insilico Medicine & Ascletis Networking Room | JOIN MEETING |
| 5:00 – 6:00 PM | Sino-Biologics & Hightide Networking Room | JOIN MEETING |
| 5:00 – 6:00 PM | Bright Future Pharmaceutical Lab Networking Room | JOIN MEETING |